Helping You Build Wealth With Honest Research
Since 1996. Try Now

MEMBER'S LOGIN

MEMBER'S LOGINX

     
Invalid Username / Password
   
     
   
     
 
Invalid Captcha
   
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

Sensex closes on a firm note
Mon, 25 Oct Closing

After a strong start in the morning, sustained buying across index heavyweights led the Indian indices to close well into the positive in the final trading hour. While the BSE Sensex closed higher by around 139 points (up 1%), the NSE Nifty gained around 40 points (up 1%). The BSE Midcap and the BSE Smallcap also notched gains of around 1% each. While gains were seen across sectors, FMCG and IT stocks were at the receiving end.

As regards global markets, barring Japan most Asian indices closed firm today while European indices have also opened in the green. The rupee was trading at Rs 44.37 to the dollar at the time of writing.

Power stocks closed mixed today. While NTPC and Reliance Infra found favour, Power Grid Corp. and Tata Power closed in the red. As per a leading business daily, power major NTPC has chalked out plans of investing Rs 200 bn for setting up a coal-based power project in Madhya Pradesh. Accordingly, it has entered into a MoU with Madhya Pradesh and MP Power Trading Company for setting up a 3,960 MW thermal power project in the state. The project is likely to be commissioned during the Twelfth Five Year Plan Period (2012-17). Initially, NTPC had envisaged setting up this plant in Uttar Pradesh. But those plans were shelved as it had differences with the state government. It must be noted that NTPC has power generation capacity of over 30,000 MW from all sources of energy and is planning to augment it to 50,000 MW by March 2012.

Dr.Reddy's announced its 2QFY11 results on Saturday. Revenues grew by a tepid 2% YoY in 2QFY11 largely due to decline in sales from the custom manufacturing business and Betapharm. Sales of Betapharm were hampered on account of price erosions caused by the impact of tenders. The North American generics business saw a 3% YoY growth in revenues in rupee terms. However, on a sequential basis, growth stood at 13% largely led by the launch of new products 'Tacrolimus' and 'Amlodipine Benazepril'. A decline in cost of sales and services (as percentage of sales) led to the 2.8% rise in operating margins during the quarter. This coupled with lower depreciation charges and significant reduction in tax expenses aided the 32% YoY growth in bottomline. The stock closed higher today.

For information on how to pick stocks that have the potential to deliver big returns, download our special report now!

View all commentaries | Archives

Read the latest Market Commentary


Equitymaster requests your view! Post a comment on "Sensex closes on a firm note". Click here!

  
ABOUT EQUITYMASTER

Since 1996, Equitymaster has been the source for honest and credible opinions on investing in India. With solid research and in-depth analysis Equitymaster is dedicated towards making its readers- smarter, more confident and richer every day. Here's why hundreds of thousands of readers spread across more than 70 countries Trust Equitymaster.

PREMIUM PRODUCTS
QUICK LINKS
POPULAR TOPICS
TRENDING TOPICS
FREE NEWSLETTERS
EQUITYMASTER SUPPORTS
  • HelpYourNGO
  • You Tube
  • Linkedin
  • Twitter
  • Telegram
  • Google Play

Copyright © Equitymaster Agora Research Private Limited.

Whitelist | Refer | Terms | Privacy | Contact | About | Sitemap

Phone +91-9136015013

Equitymaster Agora Research Private Limited (Research Analyst)
SEBI (Research Analysts) Regulations 2014, Registration No. INH000000537.

103, Regent Chambers, Above Status Restaurant, Nariman Point, Mumbai - 400 021. India.
Telephone: +91-22-61434055. Email: info@equitymaster.com. Website: www.equitymaster.com.
CIN:U74999MH2007PTC175407

Name of the Compliance & Grievance Officer: Ms Sonal Ramachandran
Telephone: +91-22-61434003 | Email: compliance@equitymaster.com

LEGAL DISCLAIMER:
Investment in securities market are subject to market risks. Read all the related documents carefully before investing.
Registration granted by SEBI and certification from NISM in no way guarantee performance of the intermediary or provide any assurance of returns to investors.

All rights reserved. Any act of copying, reproducing or distributing this newsletter whether wholly or in part, for any purpose without the permission of Equitymaster is strictly prohibited and shall be deemed to be copyright infringement.

Equitymaster Agora Research Private Limited (Research Analyst) bearing Registration No. INH000000537 (hereinafter referred as 'Equitymaster') is an independent equity research Company. Equitymaster is not an Investment Adviser. Information herein should be regarded as a resource only and should be used at one's own risk. This is not an offer to sell or solicitation to buy any securities and Equitymaster will not be liable for any losses incurred or investment(s) made or decisions taken/or not taken based on the information provided herein. Information contained herein does not constitute investment advice or a personal recommendation or take into account the particular investment objectives, financial situations, or needs of individual subscribers. Before acting on any recommendation, subscribers should consider whether it is suitable for their particular circumstances and, if necessary, seek an independent professional advice. This is not directed for access or use by anyone in a country, especially, USA, Canada or the European Union countries, where such use or access is unlawful or which may subject Equitymaster or its affiliates to any registration or licensing requirement. All content and information is provided on an 'As Is' basis by Equitymaster. Information herein is believed to be reliable but Equitymaster does not warrant its completeness or accuracy and expressly disclaims all warranties and conditions of any kind, whether express or implied. Equitymaster may hold shares in the company/ies discussed herein. As a condition to accessing Equitymaster content and website, you agree to our Terms and Conditions of Use, available here. The performance data quoted represents past performance and does not guarantee future results.